NCT01593176

Brief Summary

The investigators are doing this research study to look at how distal femoral fractures (knee bone break) heal. In this study, the investigators will use Radiostereometric Analysis (RSA) to look at how the pieces of femur bone move as the bone heals. RSA is a special x-ray that uses radiographs to measure very small movements in the bone over time. The question that will be answered by this study is whether RSA can be used as a tool to monitor fracture healing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2012

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 8, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

May 6, 2015

Status Verified

May 1, 2015

Enrollment Period

3 years

First QC Date

May 2, 2012

Last Update Submit

May 4, 2015

Conditions

Keywords

FemurFractureRadiostereometric Analysis

Outcome Measures

Primary Outcomes (1)

  • Change in inter-fragmentary motion throughout the course of healing for distal femoral fractures.

    Use radiostereometric analysis to measure inter-fragmentary motion

    Change in inter-fragmentary motion from baseline at 2 weeks, 6 weeks, 3 months, 6 months and 1 year postoperatively

Study Arms (1)

Distal Femur Fracture, LISS Plate

Patients presenting with a distal femur fracture requiring surgical fixation with a Less Invasive Stabilization System (LISS) plate will have placement of RSA beads for analysis.

Procedure: Placement of RSA beads

Interventions

At the time of surgery sets of up to 9 RSA beads will be implanted on sides of the main fractures lines with the use of the inserter instrument and the image intensifier. In AO/OTA type 33A fractures two sets will be implanted - one in the femoral shaft and one in the distal femoral epiphysis. In AO/OTA type 33C fractures with an extra fracture line through the epiphysis, three sets will be implanted - one in the femoral shaft, one in the main lateral condyle segment and one in the main medial condyle segment. No beads will be planted in comminuted bone fragments. The fracture will then be plated with a LISS plate as it normally would.

Also known as: RSA Biomedical Tantulum Markers, Synthes Less Invasive Stabilization System Fixation Plate
Distal Femur Fracture, LISS Plate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All potential subjects will be in the inpatient setting of Massachusetts General Hospital or Brigham \& Women's Hospital at the time of recruitment awaiting surgery on their distal femur fracture

You may qualify if:

  • Male or female subjects aged 18 and older
  • Isolated distal femur fracture requiring surgical stabilization with a LISS plate
  • Subjects who are able to return to MGH for follow-up during the year following their injury.

You may not qualify if:

  • Subjects with expected limited life span less than a year.
  • Subjects who were non ambulatory prior to their injury
  • Female subjects who are pregnant
  • Subjects who are treated with an orthopaedic implant other than the LISS
  • Subjects with bone structure illnesses.
  • Pathologic fractures secondary to neoplasm
  • Subject with a severe open distal femur fracture with vascular damage
  • Subjects who are unable to attend post-operative outpatient appointments at the MGH

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

Brigham & Women's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

MeSH Terms

Conditions

Femoral Fractures, DistalFractures, Bone

Condition Hierarchy (Ancestors)

Femoral FracturesWounds and InjuriesLeg Injuries

Study Officials

  • Mark S Vrahas, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
  • Charles Bragdon, Ph.D

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
  • Michael J Weaver, MD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mark S Vrahas, MD

CONTACT

Jordan H Morgan, BS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Orthopaedic Trauma Service

Study Record Dates

First Submitted

May 2, 2012

First Posted

May 8, 2012

Study Start

May 1, 2012

Primary Completion

May 1, 2015

Study Completion

June 1, 2015

Last Updated

May 6, 2015

Record last verified: 2015-05

Locations